European Pharmaceutical Manufacturer editor, Felicity Thomas, sits down with Sally Waterman, COO at Medherant to discuss the benefits of transdermal drug delivery and how industry developments and changes in patient needs are leading to a shift…
In this article, Felicity Thomas, EPM editor, discusses connected solutions for drug delivery in the ophthalmic space and how this may help with patient adherence among other things with Fanny Sellier, from Nemera.
In this online exclusive, Tomasz Bokas, Saneca Pharma, discusses the benefits of soft gel capsules, the manufacturing and handling considerations that should be considered and overcoming the potential barriers to their adoption by manufacturers.
As a new era of digital drug delivery is making headway, Dr Steven Wick, vice president, Product Development & Commercialisation, 3M Drug Delivery Systems, gives us his thoughts on this digital future.
The US Food and Drug Administration (FDA) has granted orphan drug designation to Crossject's treatment for status epilepticus (epileptic seizure lasting longer than five minutes), ZENEO Midazolam.
Research from a team led by the Technical University of Munich (TUM) has uncovered a breakthrough in peptide chemistry that may enable the administration of peptide active agents orally.
We sit down with Dirk Leister, technical marketing manager, Thermo Fisher Scientific, to find out more about hot melt extrusion and the company’s new automated, integrated system designed for continuous production of drug implants.
Do you encounter difficulties when swallowing tablets? Head of product development at Catalent Pharma Solutions, Ralph Gosden, reveals why the Zydis platform is still a game changer, and what is on the cards for the near future.
Oral solid dosage is still the preferred method of drug delivery, however, the patient’s experience when taking medication can mean they adhere to the regimen or not. Here, Dr Brian Wilson and Dr Graeme MacLeod from SPI Pharma look at the challenges
The trend of self-administered therapies is expected to grow, according to research, however, self-administrative devices need to be safe, intuitive and reliable with a design that supports patient adherence. Here, SHL detail some key considerations.
The field of prefillable syringes is constantly changing, driven by the innovations in active ingredients and patient safety at affordable costs. Here Bernd Zeiss, manager technical support medical systems, business development at Gerresheimer reveal
In this article Vasiliki Nikolaou and David M. Haddleton from Medherant, The Venture Centre University of Warwick Science Park, detail transdermal drug delivery, a non-invasive option that has the potential to improve patient adherence.
